Romin Nabiey - 08 Sep 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Chief Accounting Officer
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Romin Nabiey
Issuer symbol
GDRX
Transactions as of
08 Sep 2024
Net transactions value
-$34,209
Form type
4
Filing time
09 Sep 2024, 20:01:07 UTC
Previous filing
14 Aug 2024
Next filing
18 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +10,201 +16% 74,834 08 Sep 2024 Direct F1
transaction GDRX Class A Common Stock Tax liability $28,064 -3,640 -4.9% $7.71 71,194 08 Sep 2024 Direct
transaction GDRX Class A Common Stock Options Exercise +2,232 +3.1% 73,426 08 Sep 2024 Direct F1
transaction GDRX Class A Common Stock Tax liability $6,145 -797 -1.1% $7.71 72,629 08 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Options Exercise $0 -10,201 -11% $0.000000 81,606 08 Sep 2024 Class A Common Stock 10,201 Direct F1, F2
transaction GDRX Restricted Stock Unit Options Exercise $0 -2,232 -6.7% $0.000000 31,252 08 Sep 2024 Class A Common Stock 2,232 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
F3 The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.